Complying with new global labeling/traceability rules: piecemeal vs data-centric approach
This article was originally published in Clinica
Executive Summary
International regulatory requirements are becoming ever more stringent in the medical device sector, particularly in the areas of labeling and traceability. Neil Gleghorn, CEO of labeling content management specialist Kallik, explains what the changes are and the difference between adopting a data-centric approach to labeling creation versus piecemeal solutions which address UDI traceability in isolation